Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

BACKGROUND: Dyskinesia, a major complication in the treatment of Parkinson's disease (PD), can require prolonged monitoring and complex medical management. DISCUSSION: The current paper proposes a new way to view the management of dyskinesia in an integrated fashion. We suggest that dyskinesia...

Descripción completa

Detalles Bibliográficos
Autores principales: Daneault, Jean-François, Carignan, Benoit, Sadikot, Abbas F, Panisset, Michel, Duval, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751666/
https://www.ncbi.nlm.nih.gov/pubmed/23514355
http://dx.doi.org/10.1186/1741-7015-11-76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751666/
https://www.ncbi.nlm.nih.gov/pubmed/23514355
http://dx.doi.org/10.1186/1741-7015-11-76

Ejemplares similares